Abstract
The last few years of enhancing the design of hybrid mesoporous organosilica nanoparticles
has allowed their degradation under specific pathologic conditions, which finally is showing a light
in their potential use as drug delivery systems towards clinical trials. Nevertheless, the issue
of controlling the degradation on-demand at cellular level still remains a major challenge, even if it
has lately been addressed through the incorporation of degradable organo-bridged alkoxysilanes
into the silica framework. On this basis, this mini review covers some of the most recent examples
of dierent degradable organosilica nanomaterials with potential application in nanomedicine,
from degradable non-porous to mesoporous organosilica nanoparticles (MONs), functionalized with
responsive molecular gates, and also the very promising degradable periodic mesoporous organosilica
materials (PMOs) only consisting of organosilica bridges.
has allowed their degradation under specific pathologic conditions, which finally is showing a light
in their potential use as drug delivery systems towards clinical trials. Nevertheless, the issue
of controlling the degradation on-demand at cellular level still remains a major challenge, even if it
has lately been addressed through the incorporation of degradable organo-bridged alkoxysilanes
into the silica framework. On this basis, this mini review covers some of the most recent examples
of dierent degradable organosilica nanomaterials with potential application in nanomedicine,
from degradable non-porous to mesoporous organosilica nanoparticles (MONs), functionalized with
responsive molecular gates, and also the very promising degradable periodic mesoporous organosilica
materials (PMOs) only consisting of organosilica bridges.